Trial NCT01307605

View at ClinicalTrials.gov 
Org. Study IDs: SAKK 35/10
Secondary IDs: 2010-021253-39 CELGENE-SWS-SAKK-35/10 SWS-SAKK-35-10

Last trial update was posted on 2023-06-27

MeSH Interventions

Lenalidomide Rituximab

MeSH Conditions

Lymphoma Lymphoma, Follicular

Other Conditions


Stopping Reasons

It was decided by the trial team to stop the collection of follow up data in trial SAKK 35/10.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID